[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Contraceptives Drugs Market Insights, Forecast to 2029

November 2023 | 110 pages | ID: GD8EB53A2595EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Contraceptives Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Contraceptives Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Contraceptives Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contraceptives Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Contraceptives Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Contraceptives Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bayer, Pfizer, Teva Pharmaceutical, Merck, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S and ZiZhu, etc.

By Company
  • Bayer
  • Pfizer
  • Teva Pharmaceutical
  • Merck
  • Actavis
  • Johnson & Johnson
  • Gedeon Richter
  • Novo Nordisk A/S
  • ZiZhu
  • Baijingyu
  • Huazhong
Segment by Type
  • Long-acting Contraceptives
  • Short-acting Contraceptives
  • Emergency Contraceptives
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Segment by Region
  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
  • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Contraceptives Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Contraceptives Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptives Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE

1.1 Contraceptives Drugs Product Introduction
1.2 Market by Type
  1.2.1 Global Contraceptives Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 Long-acting Contraceptives
  1.2.3 Short-acting Contraceptives
  1.2.4 Emergency Contraceptives
1.3 Market by Application
  1.3.1 Global Contraceptives Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Contraceptives Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Contraceptives Drugs Revenue by Region
  2.2.1 Global Contraceptives Drugs Revenue by Region: 2018 VS 2022 VS 2029
  2.2.2 Global Contraceptives Drugs Revenue by Region (2018-2023)
  2.2.3 Global Contraceptives Drugs Revenue by Region (2024-2029)
  2.2.4 Global Contraceptives Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Contraceptives Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Contraceptives Drugs Sales by Region
  2.4.1 Global Contraceptives Drugs Sales by Region: 2018 VS 2022 VS 2029
  2.4.2 Global Contraceptives Drugs Sales by Region (2018-2023)
  2.4.3 Global Contraceptives Drugs Sales by Region (2024-2029)
  2.4.4 Global Contraceptives Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURES

3.1 Global Contraceptives Drugs Sales by Manufacturers
  3.1.1 Global Contraceptives Drugs Sales by Manufacturers (2018-2023)
  3.1.2 Global Contraceptives Drugs Sales Market Share by Manufacturers (2018-2023)
  3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Contraceptives Drugs in 2022
3.2 Global Contraceptives Drugs Revenue by Manufacturers
  3.2.1 Global Contraceptives Drugs Revenue by Manufacturers (2018-2023)
  3.2.2 Global Contraceptives Drugs Revenue Market Share by Manufacturers (2018-2023)
  3.2.3 Global Top 10 and Top 5 Companies by Contraceptives Drugs Revenue in 2022
3.3 Global Key Players of Contraceptives Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Contraceptives Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
  3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  3.5.2 Global Contraceptives Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Contraceptives Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Contraceptives Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Contraceptives Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

4.1 Global Contraceptives Drugs Sales by Type
  4.1.1 Global Contraceptives Drugs Historical Sales by Type (2018-2023)
  4.1.2 Global Contraceptives Drugs Forecasted Sales by Type (2024-2029)
  4.1.3 Global Contraceptives Drugs Sales Market Share by Type (2018-2029)
4.2 Global Contraceptives Drugs Revenue by Type
  4.2.1 Global Contraceptives Drugs Historical Revenue by Type (2018-2023)
  4.2.2 Global Contraceptives Drugs Forecasted Revenue by Type (2024-2029)
  4.2.3 Global Contraceptives Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Contraceptives Drugs Price by Type
  4.3.1 Global Contraceptives Drugs Price by Type (2018-2023)
  4.3.2 Global Contraceptives Drugs Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

5.1 Global Contraceptives Drugs Sales by Application
  5.1.1 Global Contraceptives Drugs Historical Sales by Application (2018-2023)
  5.1.2 Global Contraceptives Drugs Forecasted Sales by Application (2024-2029)
  5.1.3 Global Contraceptives Drugs Sales Market Share by Application (2018-2029)
5.2 Global Contraceptives Drugs Revenue by Application
  5.2.1 Global Contraceptives Drugs Historical Revenue by Application (2018-2023)
  5.2.2 Global Contraceptives Drugs Forecasted Revenue by Application (2024-2029)
  5.2.3 Global Contraceptives Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Contraceptives Drugs Price by Application
  5.3.1 Global Contraceptives Drugs Price by Application (2018-2023)
  5.3.2 Global Contraceptives Drugs Price Forecast by Application (2024-2029)

6 US & CANADA

6.1 US & Canada Contraceptives Drugs Market Size by Type
  6.1.1 US & Canada Contraceptives Drugs Sales by Type (2018-2029)
  6.1.2 US & Canada Contraceptives Drugs Revenue by Type (2018-2029)
6.2 US & Canada Contraceptives Drugs Market Size by Application
  6.2.1 US & Canada Contraceptives Drugs Sales by Application (2018-2029)
  6.2.2 US & Canada Contraceptives Drugs Revenue by Application (2018-2029)
6.3 US & Canada Contraceptives Drugs Market Size by Country
  6.3.1 US & Canada Contraceptives Drugs Revenue by Country: 2018 VS 2022 VS 2029
  6.3.2 US & Canada Contraceptives Drugs Sales by Country (2018-2029)
  6.3.3 US & Canada Contraceptives Drugs Revenue by Country (2018-2029)
  6.3.4 US
  6.3.5 Canada

7 EUROPE

7.1 Europe Contraceptives Drugs Market Size by Type
  7.1.1 Europe Contraceptives Drugs Sales by Type (2018-2029)
  7.1.2 Europe Contraceptives Drugs Revenue by Type (2018-2029)
7.2 Europe Contraceptives Drugs Market Size by Application
  7.2.1 Europe Contraceptives Drugs Sales by Application (2018-2029)
  7.2.2 Europe Contraceptives Drugs Revenue by Application (2018-2029)
7.3 Europe Contraceptives Drugs Market Size by Country
  7.3.1 Europe Contraceptives Drugs Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 Europe Contraceptives Drugs Sales by Country (2018-2029)
  7.3.3 Europe Contraceptives Drugs Revenue by Country (2018-2029)
  7.3.4 Germany
  7.3.5 France
  7.3.6 U.K.
  7.3.7 Italy
  7.3.8 Russia

8 CHINA

8.1 China Contraceptives Drugs Market Size
  8.1.1 China Contraceptives Drugs Sales (2018-2029)
  8.1.2 China Contraceptives Drugs Revenue (2018-2029)
8.2 China Contraceptives Drugs Market Size by Application
  8.2.1 China Contraceptives Drugs Sales by Application (2018-2029)
  8.2.2 China Contraceptives Drugs Revenue by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Contraceptives Drugs Market Size by Type
  9.1.1 Asia Contraceptives Drugs Sales by Type (2018-2029)
  9.1.2 Asia Contraceptives Drugs Revenue by Type (2018-2029)
9.2 Asia Contraceptives Drugs Market Size by Application
  9.2.1 Asia Contraceptives Drugs Sales by Application (2018-2029)
  9.2.2 Asia Contraceptives Drugs Revenue by Application (2018-2029)
9.3 Asia Contraceptives Drugs Sales by Region
  9.3.1 Asia Contraceptives Drugs Revenue by Region: 2018 VS 2022 VS 2029
  9.3.2 Asia Contraceptives Drugs Revenue by Region (2018-2029)
  9.3.3 Asia Contraceptives Drugs Sales by Region (2018-2029)
  9.3.4 Japan
  9.3.5 South Korea
  9.3.6 China Taiwan
  9.3.7 Southeast Asia
  9.3.8 India

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

10.1 Middle East, Africa and Latin America Contraceptives Drugs Market Size by Type
  10.1.1 Middle East, Africa and Latin America Contraceptives Drugs Sales by Type (2018-2029)
  10.1.2 Middle East, Africa and Latin America Contraceptives Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Contraceptives Drugs Market Size by Application
  10.2.1 Middle East, Africa and Latin America Contraceptives Drugs Sales by Application (2018-2029)
  10.2.2 Middle East, Africa and Latin America Contraceptives Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Contraceptives Drugs Sales by Country
  10.3.1 Middle East, Africa and Latin America Contraceptives Drugs Revenue by Country: 2018 VS 2022 VS 2029
  10.3.2 Middle East, Africa and Latin America Contraceptives Drugs Revenue by Country (2018-2029)
  10.3.3 Middle East, Africa and Latin America Contraceptives Drugs Sales by Country (2018-2029)
  10.3.4 Brazil
  10.3.5 Mexico
  10.3.6 Turkey
  10.3.7 Israel
  10.3.8 GCC Countries

11 COMPANY PROFILES

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer Overview
  11.1.3 Bayer Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.1.4 Bayer Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.1.5 Bayer Recent Developments
11.2 Pfizer
  11.2.1 Pfizer Company Information
  11.2.2 Pfizer Overview
  11.2.3 Pfizer Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.2.4 Pfizer Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.2.5 Pfizer Recent Developments
11.3 Teva Pharmaceutical
  11.3.1 Teva Pharmaceutical Company Information
  11.3.2 Teva Pharmaceutical Overview
  11.3.3 Teva Pharmaceutical Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.3.4 Teva Pharmaceutical Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.3.5 Teva Pharmaceutical Recent Developments
11.4 Merck
  11.4.1 Merck Company Information
  11.4.2 Merck Overview
  11.4.3 Merck Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.4.4 Merck Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.4.5 Merck Recent Developments
11.5 Actavis
  11.5.1 Actavis Company Information
  11.5.2 Actavis Overview
  11.5.3 Actavis Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.5.4 Actavis Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.5.5 Actavis Recent Developments
11.6 Johnson & Johnson
  11.6.1 Johnson & Johnson Company Information
  11.6.2 Johnson & Johnson Overview
  11.6.3 Johnson & Johnson Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.6.4 Johnson & Johnson Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.6.5 Johnson & Johnson Recent Developments
11.7 Gedeon Richter
  11.7.1 Gedeon Richter Company Information
  11.7.2 Gedeon Richter Overview
  11.7.3 Gedeon Richter Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.7.4 Gedeon Richter Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.7.5 Gedeon Richter Recent Developments
11.8 Novo Nordisk A/S
  11.8.1 Novo Nordisk A/S Company Information
  11.8.2 Novo Nordisk A/S Overview
  11.8.3 Novo Nordisk A/S Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.8.4 Novo Nordisk A/S Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.8.5 Novo Nordisk A/S Recent Developments
11.9 ZiZhu
  11.9.1 ZiZhu Company Information
  11.9.2 ZiZhu Overview
  11.9.3 ZiZhu Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.9.4 ZiZhu Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.9.5 ZiZhu Recent Developments
11.10 Baijingyu
  11.10.1 Baijingyu Company Information
  11.10.2 Baijingyu Overview
  11.10.3 Baijingyu Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.10.4 Baijingyu Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.10.5 Baijingyu Recent Developments
11.11 Huazhong
  11.11.1 Huazhong Company Information
  11.11.2 Huazhong Overview
  11.11.3 Huazhong Contraceptives Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.11.4 Huazhong Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.11.5 Huazhong Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

12.1 Contraceptives Drugs Industry Chain Analysis
12.2 Contraceptives Drugs Key Raw Materials
  12.2.1 Key Raw Materials
  12.2.2 Raw Materials Key Suppliers
12.3 Contraceptives Drugs Production Mode & Process
12.4 Contraceptives Drugs Sales and Marketing
  12.4.1 Contraceptives Drugs Sales Channels
  12.4.2 Contraceptives Drugs Distributors
12.5 Contraceptives Drugs Customers

13 MARKET DYNAMICS

13.1 Contraceptives Drugs Industry Trends
13.2 Contraceptives Drugs Market Drivers
13.3 Contraceptives Drugs Market Challenges
13.4 Contraceptives Drugs Market Restraints

14 KEY FINDINGS IN THE GLOBAL CONTRACEPTIVES DRUGS STUDY


15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES

Table 1. Global Contraceptives Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Long-acting Contraceptives
Table 3. Major Manufacturers of Short-acting Contraceptives
Table 4. Major Manufacturers of Emergency Contraceptives
Table 5. Global Contraceptives Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Contraceptives Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Contraceptives Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Contraceptives Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Contraceptives Drugs Revenue Market Share by Region (2018-2023)
Table 10. Global Contraceptives Drugs Revenue Market Share by Region (2024-2029)
Table 11. Global Contraceptives Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Contraceptives Drugs Sales by Region (2018-2023) & (K MT)
Table 13. Global Contraceptives Drugs Sales by Region (2024-2029) & (K MT)
Table 14. Global Contraceptives Drugs Sales Market Share by Region (2018-2023)
Table 15. Global Contraceptives Drugs Sales Market Share by Region (2024-2029)
Table 16. Global Contraceptives Drugs Sales by Manufacturers (2018-2023) & (K MT)
Table 17. Global Contraceptives Drugs Sales Share by Manufacturers (2018-2023)
Table 18. Global Contraceptives Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Contraceptives Drugs Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Contraceptives Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Contraceptives Drugs Price by Manufacturers 2018-2023 (K MT)
Table 22. Global Contraceptives Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Contraceptives Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs as of 2022)
Table 24. Global Key Manufacturers of Contraceptives Drugs, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Contraceptives Drugs, Product Offered and Application
Table 26. Global Key Manufacturers of Contraceptives Drugs, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Contraceptives Drugs Sales by Type (2018-2023) & (K MT)
Table 29. Global Contraceptives Drugs Sales by Type (2024-2029) & (K MT)
Table 30. Global Contraceptives Drugs Sales Share by Type (2018-2023)
Table 31. Global Contraceptives Drugs Sales Share by Type (2024-2029)
Table 32. Global Contraceptives Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Contraceptives Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Contraceptives Drugs Revenue Share by Type (2018-2023)
Table 35. Global Contraceptives Drugs Revenue Share by Type (2024-2029)
Table 36. Contraceptives Drugs Price by Type (2018-2023) & (K MT)
Table 37. Global Contraceptives Drugs Price Forecast by Type (2024-2029) & (K MT)
Table 38. Global Contraceptives Drugs Sales by Application (2018-2023) & (K MT)
Table 39. Global Contraceptives Drugs Sales by Application (2024-2029) & (K MT)
Table 40. Global Contraceptives Drugs Sales Share by Application (2018-2023)
Table 41. Global Contraceptives Drugs Sales Share by Application (2024-2029)
Table 42. Global Contraceptives Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Contraceptives Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Contraceptives Drugs Revenue Share by Application (2018-2023)
Table 45. Global Contraceptives Drugs Revenue Share by Application (2024-2029)
Table 46. Contraceptives Drugs Price by Application (2018-2023) & (K MT)
Table 47. Global Contraceptives Drugs Price Forecast by Application (2024-2029) & (K MT)
Table 48. US & Canada Contraceptives Drugs Sales by Type (2018-2023) & (K MT)
Table 49. US & Canada Contraceptives Drugs Sales by Type (2024-2029) & (K MT)
Table 50. US & Canada Contraceptives Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Contraceptives Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Contraceptives Drugs Sales by Application (2018-2023) & (K MT)
Table 53. US & Canada Contraceptives Drugs Sales by Application (2024-2029) & (K MT)
Table 54. US & Canada Contraceptives Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Contraceptives Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Contraceptives Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Contraceptives Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Contraceptives Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Contraceptives Drugs Sales by Country (2018-2023) & (K MT)
Table 60. US & Canada Contraceptives Drugs Sales by Country (2024-2029) & (K MT)
Table 61. Europe Contraceptives Drugs Sales by Type (2018-2023) & (K MT)
Table 62. Europe Contraceptives Drugs Sales by Type (2024-2029) & (K MT)
Table 63. Europe Contraceptives Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Contraceptives Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Contraceptives Drugs Sales by Application (2018-2023) & (K MT)
Table 66. Europe Contraceptives Drugs Sales by Application (2024-2029) & (K MT)
Table 67. Europe Contraceptives Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Contraceptives Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Contraceptives Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Contraceptives Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Contraceptives Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Contraceptives Drugs Sales by Country (2018-2023) & (K MT)
Table 73. Europe Contraceptives Drugs Sales by Country (2024-2029) & (K MT)
Table 74. China Contraceptives Drugs Sales by Type (2018-2023) & (K MT)
Table 75. China Contraceptives Drugs Sales by Type (2024-2029) & (K MT)
Table 76. China Contraceptives Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Contraceptives Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Contraceptives Drugs Sales by Application (2018-2023) & (K MT)
Table 79. China Contraceptives Drugs Sales by Application (2024-2029) & (K MT)
Table 80. China Contraceptives Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Contraceptives Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Contraceptives Drugs Sales by Type (2018-2023) & (K MT)
Table 83. Asia Contraceptives Drugs Sales by Type (2024-2029) & (K MT)
Table 84. Asia Contraceptives Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Contraceptives Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Contraceptives Drugs Sales by Application (2018-2023) & (K MT)
Table 87. Asia Contraceptives Drugs Sales by Application (2024-2029) & (K MT)
Table 88. Asia Contraceptives Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Contraceptives Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Contraceptives Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Contraceptives Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Contraceptives Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Contraceptives Drugs Sales by Region (2018-2023) & (K MT)
Table 94. Asia Contraceptives Drugs Sales by Region (2024-2029) & (K MT)
Table 95. Middle East, Africa and Latin America Contraceptives Drugs Sales by Type (2018-2023) & (K MT)
Table 96. Middle East, Africa and Latin America Contraceptives Drugs Sales by Type (2024-2029) & (K MT)
Table 97. Middle East, Africa and Latin America Contraceptives Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Contraceptives Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Contraceptives Drugs Sales by Application (2018-2023) & (K MT)
Table 100. Middle East, Africa and Latin America Contraceptives Drugs Sales by Application (2024-2029) & (K MT)
Table 101. Middle East, Africa and Latin America Contraceptives Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Contraceptives Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Contraceptives Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Contraceptives Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Contraceptives Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Contraceptives Drugs Sales by Country (2018-2023) & (K MT)
Table 107. Middle East, Africa and Latin America Contraceptives Drugs Sales by Country (2024-2029) & (K MT)
Table 108. Bayer Company Information
Table 109. Bayer Description and Major Businesses
Table 110. Bayer Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 111. Bayer Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Bayer Recent Developments
Table 113. Pfizer Company Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 116. Pfizer Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Pfizer Recent Developments
Table 118. Teva Pharmaceutical Company Information
Table 119. Teva Pharmaceutical Description and Major Businesses
Table 120. Teva Pharmaceutical Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 121. Teva Pharmaceutical Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Teva Pharmaceutical Recent Developments
Table 123. Merck Company Information
Table 124. Merck Description and Major Businesses
Table 125. Merck Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 126. Merck Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Merck Recent Developments
Table 128. Actavis Company Information
Table 129. Actavis Description and Major Businesses
Table 130. Actavis Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 131. Actavis Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Actavis Recent Developments
Table 133. Johnson & Johnson Company Information
Table 134. Johnson & Johnson Description and Major Businesses
Table 135. Johnson & Johnson Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 136. Johnson & Johnson Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Johnson & Johnson Recent Developments
Table 138. Gedeon Richter Company Information
Table 139. Gedeon Richter Description and Major Businesses
Table 140. Gedeon Richter Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 141. Gedeon Richter Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Gedeon Richter Recent Developments
Table 143. Novo Nordisk A/S Company Information
Table 144. Novo Nordisk A/S Description and Major Businesses
Table 145. Novo Nordisk A/S Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 146. Novo Nordisk A/S Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Novo Nordisk A/S Recent Developments
Table 148. ZiZhu Company Information
Table 149. ZiZhu Description and Major Businesses
Table 150. ZiZhu Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 151. ZiZhu Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. ZiZhu Recent Developments
Table 153. Baijingyu Company Information
Table 154. Baijingyu Description and Major Businesses
Table 155. Baijingyu Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 156. Baijingyu Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Baijingyu Recent Developments
Table 158. Huazhong Company Information
Table 159. Huazhong Description and Major Businesses
Table 160. Huazhong Contraceptives Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 161. Huazhong Contraceptives Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Huazhong Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Contraceptives Drugs Distributors List
Table 166. Contraceptives Drugs Customers List
Table 167. Contraceptives Drugs Market Trends
Table 168. Contraceptives Drugs Market Drivers
Table 169. Contraceptives Drugs Market Challenges
Table 170. Contraceptives Drugs Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Contraceptives Drugs Product Picture
Figure 2. Global Contraceptives Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Contraceptives Drugs Market Share by Type in 2022 & 2029
Figure 4. Long-acting Contraceptives Product Picture
Figure 5. Short-acting Contraceptives Product Picture
Figure 6. Emergency Contraceptives Product Picture
Figure 7. Global Contraceptives Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Contraceptives Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Contraceptives Drugs Report Years Considered
Figure 13. Global Contraceptives Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Contraceptives Drugs Revenue 2018-2029 (US$ Million)
Figure 15. Global Contraceptives Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Contraceptives Drugs Revenue Market Share by Region (2018-2029)
Figure 17. Global Contraceptives Drugs Sales 2018-2029 ((K MT)
Figure 18. Global Contraceptives Drugs Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Contraceptives Drugs Sales YoY (2018-2029) & (K MT)
Figure 20. US & Canada Contraceptives Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Contraceptives Drugs Sales YoY (2018-2029) & (K MT)
Figure 22. Europe Contraceptives Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Contraceptives Drugs Sales YoY (2018-2029) & (K MT)
Figure 24. China Contraceptives Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Contraceptives Drugs Sales YoY (2018-2029) & (K MT)
Figure 26. Asia (excluding China) Contraceptives Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Contraceptives Drugs Sales YoY (2018-2029) & (K MT)
Figure 28. Middle East, Africa and Latin America Contraceptives Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Contraceptives Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Contraceptives Drugs in the World: Market Share by Contraceptives Drugs Revenue in 2022
Figure 31. Global Contraceptives Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Contraceptives Drugs Sales Market Share by Type (2018-2029)
Figure 33. Global Contraceptives Drugs Revenue Market Share by Type (2018-2029)
Figure 34. Global Contraceptives Drugs Sales Market Share by Application (2018-2029)
Figure 35. Global Contraceptives Drugs Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Contraceptives Drugs Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Contraceptives Drugs Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Contraceptives Drugs Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Contraceptives Drugs Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Contraceptives Drugs Revenue Share by Country (2018-2029)
Figure 41. US & Canada Contraceptives Drugs Sales Share by Country (2018-2029)
Figure 42. U.S. Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Contraceptives Drugs Sales Market Share by Type (2018-2029)
Figure 45. Europe Contraceptives Drugs Revenue Market Share by Type (2018-2029)
Figure 46. Europe Contraceptives Drugs Sales Market Share by Application (2018-2029)
Figure 47. Europe Contraceptives Drugs Revenue Market Share by Application (2018-2029)
Figure 48. Europe Contraceptives Drugs Revenue Share by Country (2018-2029)
Figure 49. Europe Contraceptives Drugs Sales Share by Country (2018-2029)
Figure 50. Germany Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. France Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. China Contraceptives Drugs Sales Market Share by Type (2018-2029)
Figure 56. China Contraceptives Drugs Revenue Market Share by Type (2018-2029)
Figure 57. China Contraceptives Drugs Sales Market Share by Application (2018-2029)
Figure 58. China Contraceptives Drugs Revenue Market Share by Application (2018-2029)
Figure 59. Asia Contraceptives Drugs Sales Market Share by Type (2018-2029)
Figure 60. Asia Contraceptives Drugs Revenue Market Share by Type (2018-2029)
Figure 61. Asia Contraceptives Drugs Sales Market Share by Application (2018-2029)
Figure 62. Asia Contraceptives Drugs Revenue Market Share by Application (2018-2029)
Figure 63. Asia Contraceptives Drugs Revenue Share by Region (2018-2029)
Figure 64. Asia Contraceptives Drugs Sales Share by Region (2018-2029)
Figure 65. Japan Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. India Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Contraceptives Drugs Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Contraceptives Drugs Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Contraceptives Drugs Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Contraceptives Drugs Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Contraceptives Drugs Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Contraceptives Drugs Sales Share by Country (2018-2029)
Figure 76. Brazil Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Contraceptives Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Contraceptives Drugs Value Chain
Figure 82. Contraceptives Drugs Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed


More Publications